MapLight Therapeutics Inc (MPLT) Price Prediction & ForecastMPLTMapLight Therapeutics Inc

Alphio's MPLT stock price prediction model matches the current MapLight Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.06 (+1.17%). The 1-week path is $8.33 (+4.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

MapLight Therapeutics, Inc. (MPLT) is currently not a strong buy due to its low price of $7.97 and a concerning RSI of 34.376, indicating potential oversold conditions. However, the company has a significant cash position of $351.3 million, which supports its operations through 2028. The main risk is the negative sentiment from analysts, particularly UBS's downgrade to Neutral with a price target of $13, reflecting concerns over the efficacy of its lead drug candidate. Investors should be cautious and consider holding rather than buying at this time.

MapLight Therapeutics Inc (MPLT) last closed at $7.97, losing -3.39%. These facts feed the 1-day and 1-week MPLT price prediction above.